BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37339766)

  • 1. Sociodemographics, Clinical Factors, and Biological Factors Associated with Loiasis in Endemic Onchocerciasis Areas in Southern Gabon.
    Moutongo Mouandza R; Mourou JR; Moutombi Ditombi B; Roger Sibi Matotou H; Ekomi B; Bouyou-Akotet MK; Mawili-Mboumba DP
    Am J Trop Med Hyg; 2023 Oct; 109(4):850-857. PubMed ID: 37339766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
    Pion SD; Nana-Djeunga H; Niamsi-Emalio Y; Chesnais CB; Deléglise H; Mackenzie C; Stolk W; Fletcher DA; Klion AD; Nutman TB; Boussinesq M; Kamgno J
    Lancet Infect Dis; 2020 Jan; 20(1):102-109. PubMed ID: 31676244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
    Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
    Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
    N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
    Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ
    PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projected Number of People With Onchocerciasis-Loiasis Coinfection in Africa, 1995 to 2025.
    Vinkeles Melchers NVS; Coffeng LE; Boussinesq M; Pedrique B; Pion SDS; Tekle AH; Zouré HGM; Wanji S; Remme JH; Stolk WA
    Clin Infect Dis; 2020 May; 70(11):2281-2289. PubMed ID: 31304961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections.
    Richard-Lenoble D; Kombila M; Rupp EA; Pappayliou ES; Gaxotte P; Nguiri C; Aziz MA
    Am J Trop Med Hyg; 1988 Nov; 39(5):480-3. PubMed ID: 3195695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?
    Pion SD; Clarke P; Filipe JA; Kamgno J; Gardon J; Basáñez MG; Boussinesq M
    Parasitology; 2006 Jun; 132(Pt 6):843-54. PubMed ID: 16469200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
    Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
    Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection.
    Boussinesq M; Gardon J
    Ann Trop Med Parasitol; 1997 Sep; 91(6):573-89. PubMed ID: 9425360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.
    Thomson MC; Obsomer V; Dunne M; Connor SJ; Molyneux DH
    Lancet; 2000 Sep; 356(9235):1077-8. PubMed ID: 11009145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
    Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Integrated District Mapping Strategy for Loiasis to Enable Safe Mass Treatment for Onchocerciasis in Gabon.
    Ella SN; Ogoussan K; Gass K; Hundley L; Diggle PJ; Johnson O; Biamonte M; Atsame J
    Am J Trop Med Hyg; 2021 Nov; 106(2):732-739. PubMed ID: 34781262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin.
    Esum M; Wanji S; Tendongfor N; Enyong P
    Trans R Soc Trop Med Hyg; 2001; 95(6):673-6. PubMed ID: 11816443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual Localization of Blood-Borne Loa loa Microfilariae in the Skin Depends on Microfilarial Density in the Blood: Implications for Onchocerciasis Diagnosis in Coendemic Areas.
    Niamsi-Emalio Y; Nana-Djeunga HC; Chesnais CB; Pion SDS; Tchatchueng-Mbougua JB; Boussinesq M; Basáñez MG; Kamgno J
    Clin Infect Dis; 2021 Jun; 72(Suppl 3):S158-S164. PubMed ID: 33909066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loa loa Microfilariae in Skin Snips: Consequences for Onchocerciasis Monitoring and Evaluation in L. loa-Endemic Areas.
    Nana-Djeunga HC; Fossuo-Thotchum F; Pion SD; Chesnais CB; Kubofcik J; Mackenzie CD; Klion AD; Boussinesq M; Nutman TB; Kamgno J
    Clin Infect Dis; 2019 Oct; 69(9):1628-1630. PubMed ID: 30861060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loiasis is endemic in the Ndikinimeki Health District (Centre Region, Cameroon) but does not represent a hindrance to onchocerciasis elimination.
    Sumo L; Ntonifor NH; Afor AR; Bopda J; Bamou Heumou R; Ondoua Nganjou GS; Nana Djeunga HC
    Acta Trop; 2022 Jan; 225():106218. PubMed ID: 34755644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
    Bulman CA; Bidlow CM; Lustigman S; Cho-Ngwa F; Williams D; Rascón AA; Tricoche N; Samje M; Bell A; Suzuki B; Lim KC; Supakorndej N; Supakorndej P; Wolfe AR; Knudsen GM; Chen S; Wilson C; Ang KH; Arkin M; Gut J; Franklin C; Marcellino C; McKerrow JH; Debnath A; Sakanari JA
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003534. PubMed ID: 25700363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis.
    Boussinesq M; Gardon J; Gardon-Wendel N; Kamgno J; Ngoumou P; Chippaux JP
    Am J Trop Med Hyg; 1998 Apr; 58(4):461-9. PubMed ID: 9574793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.